Document

Supporting Statement B

ICR 202610-0920-023 · OMB 0920-1474 · Object 174315201.

Document Viewer [docx]

Status: Original and derived artifacts are available for this document.

Download: docx | pdf | html

Primary: docxSource: application/vnd.openxmlformats-officedocument.wordprocessingml.document
Loading document viewer…

Document Metadata

Record metadata
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Supporting Statement B
Julia Charles
Writer
2026-10-21
2026-11-14
complete

Extracted Text



2026 Ebola Passenger Disclosure and Attestation
Request for OMB approval of a New Information Collection 

October 20, 2026








Supporting Statement B



















Contact: 
Thomas J. “Chip” Daymude
National Center for Emerging and Zoonotic Infectious Diseases 
Centers for Disease Control and Prevention 
1600 Clifton Road, NE 
Atlanta, Georgia 30333 
Phone: (470) 553-3567 
Email: [email protected]
Table of Contents

1.	Respondent Universe and Sampling Methods	2
2.	Procedures for the Collection of Information	2
3.	Methods to maximize Response Rates and Deal with No Response	2
4.	Tests of Procedures or Methods to be Undertaken	3
5.	Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data	3


No statistical methods will be used. 

    1. Respondent Universe and Sampling Methods
The respondent universe for this collection is travelers arriving via air travel in the United States from foreign countries. 
    2. Procedures for the Collection of Information
Section 361 of the Public Health Service (PHS) Act (42 USC 264) (Attachment A1) authorizes the Secretary of Health and Human Services to make and enforce regulations necessary to prevent the introduction, transmission or spread of communicable diseases from foreign countries into the United States. Under its delegated authority, DGMH works to fulfill this responsibility through a variety of activities, including the administration of foreign quarantine regulations; 42 Code of Federal Regulation part 71 (Attachment A2), specifically 42 CFR 71.20 Public health prevention measures to detect communicable disease. 
On May 17, 2026, an outbreak of Ebola disease caused by Bundibugyo virus was detected in the Democratic Republic of the Congo (DRC) and Uganda.  On May 20, 2026, the Department of Homeland Security (DHS) published Arrival Restrictions Applicable to Flights Carrying Persons Who Have Recently Traveled From or Were Otherwise Present Within the Democratic Republic of the Congo (DRC), Uganda, or South Sudan.1 Airlines are instructed to redirect flights carrying persons who have recently traveled from or were otherwise present within DRC, Uganda, and South Sudan in the previous 21 days to specific ports of entry.2,3  
The Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services (HHS) issued an Order on May 18, 2026, to suspend entry into the United States of foreign nationals who were physically present in the Democratic Republic of Congo (DRC), Uganda, or South Sudan in the past 21 days. The Order was amended on May 22, 2026. An Order continuing the suspension of the right to introduce specified foreign nationals into the United States was issued on June 21, 2026, July 13, 2026, August 12, 2026, September 11, 2026, and most recently on October 11, 2026.4 
This information collection accompanies the Notice and Order (Attachment C) requiring that any traveler arriving in the United States from a foreign country submit an attestation confirming they have not been present in the Democratic Republic of the Congo (DRC) in the past 21 days before arrival in the United States. Passengers must complete the attestation as instructed by the airline before being allowed to board a flight to the United States as a public health prevention measure to mitigate the potential spread of a confirmed ongoing outbreak of Ebola virus disease caused by the Bundibugyo virus.
The Order is enforceable through the provisions of 18 U.S.C. §§ 3559, 3571 (Attachment A3); 42 U.S.C. §§ 243, 268, 271 (Attachment A1); and 42 C.F.R. § 71 (Attachment A2).

    3. Methods to maximize Response Rates and Deal with No Response
Response is required and nonresponse adjustments are not expected. 
  
    4. Tests of Procedures or Methods to be undertaken
This is a new requirement. CDC consulted with other U.S. government agencies regarding the procedures for collecting this data. 

    5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data
No statistical methods are used in this data collection. CDC consulted with other U.S. government agencies regarding the collection of this data.